Cancer vaccines: A promising role in cancer therapy

Academic Journal of Cancer Research

Volumn 3, Issue 2, 2010, Pages 16-21

  Praveen Kumar, V ^a   Prasanthi, S ^a   Lakshmi, V R S ^a   Sai Santosh, M V ^a  

^a K L UNIVERSITY   (India)

Author keywords

Cancer therapy; Cancer vaccines; Dna vaccines; Universal cancer vaccines

Indexed keywords

ALPHA INTERFERON; ANTIIDIOTYPIC ANTIBODY; ANTIIDIOTYPIC MONOCLONAL ANTIBODY 11D10 VACCINE; ANTIIDIOTYPIC MONOCLONAL ANTIBODY 3H1 VACCINE; BCG VACCINE; CANCER VACCINE; DENDRITIC CELL VACCINE; DNA; DNA VACCINE; GLYCOPROTEIN GP 100; INTERLEUKIN 2; MELAN A; MELANOMA VACCINE; MONOCLONAL ANTIBODY; MONOPHENOL MONOOXYGENASE; NY ESO 1 PEPTIDE VACCINE; ONYVAX; TUMOR APC HYBRID VACCINE; TUMOR CELL VACCINE; UNCLASSIFIED DRUG; VG 1000 VACCINE; VITESPEN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER THERAPY; CARCINOGENESIS; CARCINOMA; COLORECTAL CARCINOMA; DRUG EFFICACY; ENVIRONMENTAL FACTOR; FLU LIKE SYNDROME; GENE MUTATION; GLIOMA; HEREDITY; HUMAN; IMMUNE RESPONSE; INJECTION SITE REACTION; LEUKEMIA; LUNG NON SMALL CELL CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; NONHUMAN; RASH; SARCOMA; SOFT TISSUE SARCOMA; VACCINE PRODUCTION;

EID: 80155188579     PISSN: 19958943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jeffrey Schlom, M. Philip Arlen and L. James Gulley, 2007. Cancer Vaccines: Moving Beyond Current Paradigms, Clinical Cancer Research July 2007. 13: 3776.
2. Olivera, Fenn J., 2003. Cancer Vaccines: Between the idea and reality Nature reviews immunology. August Vol., 630.
3. Bruce N. Ames, Lois Swirsky Gold and C. Walter Willett, 1998. The causes and prevention of cancer, Biotherapy; Volume 11, Numbers 2-3/June, 1998 205-220.
4. Ames, B.N. and L.S. Gold, 1997. The causes and prevention of cancer: gaining perspective, JSTOR, Vol., 105: 4 June 1997.
5. Jennifer, L. Kelsey 1979. A review of human cancer, Epidemiological Reviews, Vol., 1.
6. Javier Hernandez, M.D., M. Ian and M.D. Thompson, 2004. A review on prostate specific cancer, Cancer Cytopathology, 101(50: 894-904. July 2004.
7. Allan Hildesheim and Sophia S. Wang, 2002. Risk of cervical cancer: a review, Virus Research November 2002, 89(2): 229-240.
8. Steven Q. Wang, B.A. Richard Setlow, Marianne Berwick, Ultraviolet A and melanoma: A review, Journal Academy of Dermatology, Vol. 44, No. 5.
9. Gerner, R.E. G.E. Moore and J.W. Pickren, 1975. Soft tissue sarcomas. Annals of Surgery, 1975 June, 181(6): 803-808.
10. John, J., M.D. Kelly, S. Donald and M.D. Karcher, Lymphoma and peripheral neuropathy: A clinical review. Muscle and Nerve, 31(3): 301-313.
11. Freeman, C. and J. Farmer, gliomas: A review, International Journal of Radiation Oncology, Biology Physics, 40(2): 265-271.
12. Murray, Brennan F., 2005. Current status of surgery for gastric cancer: a review, Gastric Cancer, Volume 8: Number 2/May, 2005.
13. Daniel, Miller W., A review of proton beam radiation therapy, Medical Physics 22(11): 1943-1954.
14. Tannock, I., 1978. Cell kinetics and chemotherapy: a critical review. Cancer Treatment. 1978 Aug., 62(8): 1117-33.
15. Boothby, Lisa A., D. Pharm Doering, L. Paul, M.S. Kipersztok and M.D. Simon, 2004. Bioidentical hormone therapy: a review, Menopause: May/June 2004 - 11(3): 356-367.
16. Old, L.J., 1996. Immunotherapy for cancer. Journal of Immunotherapy, 275: 136-143.
17. Vattemi, E. and P.P. Claudio, 2004. Gene therapy for lung cancer: practice and promise. Ann. Ital. Chir., 75: 279-289.s
18. Mulligan, R.C., 1993. The basic science of gene therapy. Sci., 260: 926-932.
19. Reiche, E., S. Nunes and H. Morimoto. Stress, depression, the immune system and cancer The Lancet Oncology, 5(10): 617-625.
20. Tannishtha Reya, J. Sean Morrison, F. Michael Clarke and L. Irving Weissman, 2001. Cancer and cancer stem cells, Nature., pp: 414.
21. David, L. Klein, 1995. Vaccines: Review and Update, Microbial Drug Resistance. Spring, 1(1): 49-58.
22. Liu, Margaret A., DNA Vaccines: A Review, Vaccines. Preventing Disease and Protecting Health, pp: 245-255(11)
23. Dallal, R.M. and M.T. Lotze, 2000. The dendritic cell and human cancer vaccines. Curr Opin Immunol., 12: 583-8.
24. Blumenthal, R.D., 2003. Technology evaluation: Onyvax-105, Onyvax, Current Opinion in Molecular Therapeutics, 5: 668-672.
25. Nizar Habal and K. Rishab Gupta, 2001. Cancer Vax, An Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and Cellular Immune Responses in Advanced Colon Cancer, Annals of Surgical Oncology, Volume 8, Number 5/June.
26. Volker Schirrmacher, 2005. Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection, Cancer Immunology, Immunotherapy, Volume 54, Number 6/June.
27. Elke Jäger, Yao-Tseng Chen, 1998. Simultaneous Humoral and Cellular Immune Response against Cancer-Testis Antigen NY-ESO-1, The J. Experimental Medicine, January 19, 187(2): 265-270.
28. Donna, Reece E. and A. Ken Foon, Use of the Anti-idiotype Breast Cancer Vaccine 11D10, Clinical Breast Cancer, Volume 3, Supplement, 4: S152-S157.
29. Flora Wang, 1999. Elizabeth Bade. Phase I Trial of Tyrosinase, gp100 and MART-1 Peptide Vaccine with Incomplete Freund's Adjuvant for Resected High-Risk Melanoma, Clinical Cancer Research October, 5: 2756.
30. Heidi Hörig, David S. Lee and I. Phase, 2000. Clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule, Cancer Immunology, Immunotherapy,/ October., 49(9): 504-514.
31. Vasanthi, N.S., 2006. Cancer vaccines: The new fight against cancer, Resonance, Volume 11, Number 11/November, pp: 48-55.
32. Garnett, Charlie T. and W. Greiner, 2006. John TRICOM Vector Based Cancer Vaccines, Current Pharmaceutical Design, January 2006, 12(3): 351-361(11).
33. Oki, Yasuhiro Younes, 2004. Anas. Heat shock protein-based cancer vaccines, Expert Review of Vaccines, August, 3(4): 403-411(9).
34. Elke Jäger, Dirk Jäger and Alexander Knuth, 2002. Clinical cancer vaccine trials: A Review, Current Opinion in Immunology, 1 April 2002, 14(2): 178-182.